BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Saturday, June 13, 2026
Home
»
Newsletters
» BioWorld MedTech
BioWorld MedTech
Oct. 10, 2012
View Archived Issues
Financings roundup: LoneStar Heart completes $20M milestone-based fund
Read More
Washington roundup: IsoAid warned over validation procedures, sterilization issues
Read More
Deals roundup:Boston Scientific to acquire Rhythmia for up to $265M
Read More
Agreements/contracts : RI Research awarded FAIR project, valued at $5.8 million
Read More
HIT roundup: SMS to provide support for DoD and VA iEHR initiative
Read More
Med-Tech News
Read More
People in the News
Read More
Product Briefs
Read More
MDD's Oncology Extra
Read More
Edwards' third quarter sales weak, but rebound expected
Edwards Lifesciences (Irvine, California) reported unexpectedly weak third quarter sales, but both the company and analysts say near-term catalysts should boost fourth quarter and 2013 sales.
Read More
FDA grants Integra expanded indication for spine application
Read More
